Area of Research: Genetic Markers
2016 Grant Recipients
-
Pradeep Chaluvally-Raghavan, PhD,
Medical College of Wisconsin
Early Career Investigator GrantUnexpected Role of CLDN11 cdRNA in Ovarian Cancer
2015 Grant Recipients
-
Michael Yaffe, MD, PhD,
Massachusetts Institute of Technology
Collaborative Research Development GrantUsing Functional Genetics and Nanomedicine for Ovarian Cancer Treatments
-
Nicole Spardy, PhD,
Dana Farber Cancer Institute
Mentored Investigator GrantIdentification of New Genetic Dependencies in HR-deficient Ovarian Cancers
-
Daniela Dinulescu, PhD,
Brigham and Women’s Hospital
Early Career Investigator GrantModeling Serous Ovarian Carcinoma Using Genetic Markers Specific for the Distal Fallopian Tube
2014 Grant Recipients
-
Rachel Grisham, MD,
Memorial Sloan Kettering Cancer Center
Early Career Investigator GrantDetermining the Molecular Drivers of Low-Grade Serous Ovarian Cancer
-
Barbara Stulken Norquist, MD,
University of Washington
Early Career Investigator GrantMolecular Biomarkers to Predict PARP Inhibitor Response in Ovarian Cancer
-
Ellen Cheon, PhD,
Cedars-Sinai Medical Center
Mentored Investigator GrantCollagen-Remodeling Genes Provide a Niche for Ovarian Cancer
2013 Grant Recipients
-
Simon Gayther, PhD,
University of Southern California
Collaborative Research Development GrantFunctional Analysis of Genetic Susceptibility Loci to Identify Biomarkers and Candidate Genes Associated with Ovarian Cancer Initiation, Progression and Outcome
-
Pradeep Chaluvally-Raghavan, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantRole of microRNAs in the 3q26 Amplicon in Ovarian Cancer Pathophysiology and Therapy
-
David Pepin, PhD,
Massachusetts General Hospital
Mentored Investigator GrantMechanisms and Markers to Target a Stem Enriched Population of Primary Ovarian Cancer Ascites with the Müllerian Inhibiting Substance
2012 Grant Recipients
-
Bin Guan, PhD,
Johns Hopkins University School of Medicine
Mentored Investigator GrantFunctional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
-
Kate Lawrenson, PhD,
University of Southern California
Mentored Investigator GrantModeling Stem Cell Origins of Epithelial Ovarian Carcinomas
-
Daniela Dinulescu, PhD,
Brigham and Women’s Hospital
Early Career Investigator GrantModeling Serous Ovarian Carcinoma Using Genetic Markers Specific for the Distal Fallopian Tube
-
See-Hyoung Park, PhD,
Stanford University
Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
-
Sharmistha Sarkar, PhD,
MD Anderson Cancer Center
Mentored Investigator GrantFinding a Marker to Detect Early Stage Ovarian Cancer
2009 Grant Recipients
-
Andrew Berchuck, MD,
Duke University Medical Center
Collaborative Research Development GrantInternational Ovarian Cancer Association Consortium: Finding Genetic Markers of Ovarian Cancer Using Polymorphisms
2008 Grant Recipients
-
Takayo Ota, MD, PhD,
Mayo Clinic Rochester
Mentored Investigator GrantCharacterizing the Genetic Alterations of Aggressive Ovarian Cancer
2007 Grant Recipients
-
John Risinger, PhD,
Michigan State University
Individual Investigator AwardUnderstanding the Genetics of Metastasis May Help Prevent and Stop It
2006 Grant Recipients
-
Ramandeep Rattan, PhD,
Mayo Clinic
Mentored Investigator GrantGene May Be an Early Marker for Ovarian Cancer
-
Andres Matoso, MD,
Cornell University
Mentored Investigator GrantAn Animal Model to Study Major Genetic Alterations in Ovarian Cancer
-
Maria Barbolina, PhD,
University of Illinois - Chicago
Mentored Investigator GrantEpigenetic Regulation of Metastasis-Associated Gene Expression in EOC
2005 Grant Recipients
-
Andrew Berchuck, MD,
Duke University Medical Center
Collaborative Research Development GrantInternational Ovarian Cancer Association Consortium
2004 Grant Recipients
-
Xiaoyan Ni, PhD,
Brigham and Women’s Hospital
Mentored Investigator GrantBiomarkers for Ovarian Cancer
2003 Grant Recipients
-
Changping Zou, MD, PhD,
University of Arizona
Individual Investigator AwardFinding Biomarkers for Early Detection of Ovarian Cancer
-
Monique Spillman, MD, PhD,
Duke University Medical Center
Mentored Investigator GrantRole of MAP2K4 Suppressing Metastasis of Serous Ovarian Cancers
-
Kuan-Chun Huang, PhD,
Brigham and Women’s Hospital
Mentored Investigator GrantA Possible New Marker for Drug Resistance of Ovarian Cancer
2002 Grant Recipients
-
Andrew K. Godwin, PhD,
Fox Chase Cancer Center
Individual Investigator AwardIdentification of Novel Genetic Markers of Response to Imatinib Mesylate in Ovarian Carcinomas
-
Fergus Couch, PhD,
Mayo Clinic
Individual Investigator AwardFinding Genes Associated with Drug Resistance in Ovarian Cancer
2001 Grant Recipients
-
Jingwei Yu, PhD,
Eleanor Roosevelt Institute
Individual Investigator AwardDevelopment of DNA Methylation Based Ovarian Cancer Specific Molecular Markers
2000 Grant Recipients
-
Iman Osman, MD,
University of New Mexico
Individual Investigator AwardHypoxia Inducible Factor-1 alpha (HIF-1): A Potential New Prognostic Marker for Advanced Ovarian Cancer and Target of Treatment